Overview

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This study is a 3-arm, double-blind, randomized trial comparing the clinical outcomes of Zilretta, Synvisc One, and Monovisc for knee OA.
Phase:
Phase 4
Details
Lead Sponsor:
Ohio State University
Treatments:
Hylan